Go Backs
HomeCategoriesStatesCheck Your Home
Go Backs

Track product recalls and safety alerts from CPSC, FDA, NHTSA, and USDA. Stay informed and keep your family safe.

Browse

  • Categories
  • States
  • Check Your Home
  • Risk Levels

Agencies

  • CPSC
  • FDA Food
  • FDA Drug
  • FDA Device
  • FDA Veterinary
  • NHTSA
  • USDA

Company

  • About
  • FAQ
  • Contact
  • Terms of Service
  • Privacy Policy
Buy Me a Coffee

Recall data is sourced from official U.S. government agencies (CPSC, FDA, NHTSA, USDA) and processed using AI to improve readability. This site is not affiliated with or endorsed by any government agency. Always refer to the original agency notice for authoritative information.

ยฉ 2026 Go Backs. All rights reserved.

Medium RiskFDA Device
Medical Devices/Diagnostic Equipment

Senographe Pristina Mammography Systems Recalled for Incorrect X-Ray Labels

Agency Publication Date: December 9, 2025
Share:
Sign in to monitor this recall

Summary

GE Medical Systems, LLC is recalling approximately 1,818 Senographe Pristina, Pristina Serena, and Pristina Serena 3D systems used for screening and diagnostic mammography. These systems were distributed with either a missing or an incorrect X-ray warning label, which does not meet federal safety regulations. Facility managers and healthcare providers should contact the manufacturer to arrange for the installation of the correct safety labels.

Risk

The incorrect or missing labels fail to provide the required safety warnings regarding X-ray radiation. This could lead to a misunderstanding of the device's operation or safety precautions, although the functional performance of the imaging system itself is not affected.

What You Should Do

  1. This recall affects Senographe Pristina, Pristina Serena, and Pristina Serena 3D systems used for mammography screenings.
  2. Identify affected systems by checking for the following Global Trade Item Numbers (GTINs) on the device labeling: 00840682118460, 00840682142052, 00840682145879, 00195278022745, 00195278276971, 00195278661999, 00195278665379, and 00195278914026.
  3. Stop using the recalled device. Contact GE Medical Systems, LLC or your authorized distributor to arrange for a label correction, replacement, or further instructions.
  4. Call the FDA at 1-888-463-6332 (1-888-INFO-FDA) for additional information regarding this recall.

Your Remedy Options

๐Ÿ“‹Other Action
How to: Stop using the recalled device. Contact the manufacturer or your distributor to arrange return, replacement, or correction.

Affected Products

Product: Senographe Pristina, Pristina Serena, and Pristina Serena 3D Mammography Systems
Variants: Senographe Pristina, Pristina Serena, Pristina Serena 3D
GTIN:
00840682118460
00840682142052
00840682145879
00195278022745
00195278276971
00195278661999
00195278665379
00195278914026

Quantity affected: 1,818 (1,580 US; 238 OUS). Systems are for screening and diagnostic mammography.

Additional Information

Agency: Food and Drug Administration (FDA)
Event ID: 98081
Status: Active
Manufacturer: GE Medical Systems, LLC
Sold By: Medical equipment distributors
Manufactured In: United States
Units Affected: 1,818 (1,580 US; 238 OUS)
Distributed To: Nationwide

Were You Affected by This Recall?

If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.

Find an Attorney

This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.

AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.

Sources: FDA iRES ยท Raw API Response

openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.